IXHL
Incannex Healthcare Inc.
Key Financials
Operating Income
$-23027000
↑ 3.2%
Net Income
$-19302000
↑ 58.8%
Revenue
$12000
N/A
Shareholders' Equity
$67.4M
↑ 403.2%
Total Liabilities
$5.6M
↓ 20.6%
EPS (Diluted)
$-1.66
↓ 23.0%
Total Assets
$73.0M
↑ 256.9%
Cash & Equivalents
$67.7M
↑ 350.2%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| 10-K | 9/25/2026 | View on SEC |
| 8-K | 9/9/2026 | View on SEC |
| 8-K | 8/25/2026 | View on SEC |
| SCHEDULE 13G | 8/14/2026 | View on SEC |
| 8-K | 8/11/2026 | View on SEC |
| 8-K | 7/23/2026 | View on SEC |
| 8-K | 6/25/2026 | View on SEC |
| 8-K | 6/10/2026 | View on SEC |
| 8-K | 6/9/2026 | View on SEC |
| 10-Q | 5/15/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | IXHL |
| Company Name | Incannex Healthcare Inc. |
| CIK | 1873875 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer Smaller reporting company Emerging growth company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 0630 |
| State of Incorporation | DE |
| Phone | 61 409 840 786 |